Nanoparticle Research
Leverage the power of flow cytometry for the detection and characterization of cellular origin nanoparticles
Interest in nanoparticles of cellular origin is exploding due to new insights into the role these particles play in extracellular communication processes and the potential for detecting pathological states via liquid biopsy.
Several fundamental capabilities of flow cytometry make this an attractive platform for extracellular vesicle research, such as the ability to detect large numbers of events and discriminate rare events while collecting information on surface composition.
Recent developments in laser and electronics design pushed the boundaries of reliably detecting events in the nanoparticle size range. The CytoFLEX Flow Cytometer is the first benchtop instrument with acceptable noise-to-signal discrimination for the reliable detection of particles down to 80 nm.
Nanoparticle Resources
- Filter by:
Title | Description |
---|---|
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{9D4654A7-15C9-4E79-B36C-0A63830E2320}|{D62418F5-2B8B-4155-AC0E-3ABFBF3E7911} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{A7DF4F56-8AF9-4BF1-88BE-766AB73FBC6B} | |
{749D68FB-4893-4B2D-BD6C-C662F0520F64} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{749D68FB-4893-4B2D-BD6C-C662F0520F64} | |
{A7DF4F56-8AF9-4BF1-88BE-766AB73FBC6B} | |
{A7DF4F56-8AF9-4BF1-88BE-766AB73FBC6B} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
How can I differentiate between particulate in the sample, the sample probe, or the sheath solution?
{C761825C-5739-42D5-90E3-D058FB587ADC}
|
|
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{611E05FD-FC41-4E23-9498-DA5662F8D4F9} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{C761825C-5739-42D5-90E3-D058FB587ADC} | |
{611E05FD-FC41-4E23-9498-DA5662F8D4F9} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{442DF88C-CA7F-4B78-AF75-9D2B985534C0} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} | |
{FBC52A26-B43E-46C3-A091-65AAEFBE5885}|{8ED0B7A0-4EDF-41AC-9D0B-3950E79F42E4} |
Additional Research Topics and Information
-
Research Areas
-
Immunotherapy
- About Immunotherapy
- CAR-T Cells: Immuno-oncology Therapeutics
- About Viral Vectors
- Pediatric Immunotherapy
- Manufacturing Processes for Engineered T-Cell Therapy – CAR-T
- Immunotherapy Research: Supporting Products
- Immunotherapy Shows Renewed Promise for Cancer Therapies
- Cell Therapy: From Research to Commercialization
- CRISPR for Immunotherapy
- Characterizing Viral Vectors: Analyzing rAAV Vector Homogeneity
- Developing and Producing Viral Vectors: Powering Forward Momentum for the Future of Gene Therapy
- 3D Cell Culture
- High Complexity Flow
- Dendritic Cells
-
HIV Advanced Disease Management
- Twelve Steps to CD4 Testing
-
HIV Advanced Disease Management Solutions
- AQUIOS CL Flow Cytometry System
- AQUIOS Tetra – Fast, Efficient, High Throughput Lymphocyte Subset Analysis
- Comparing the AQUIOS CL PLG Application to the FC500 MCL FlowCARE PLG Application
- Enumeration of T, B, and NK Subpopulations in Aged Whole Blood Samples Using The AQUIOS CL Instruments with Tetra Application
- AQUIOS PLG (PanLeukoGating)
- Error Prevention at Sample Preparation on the AQUIOS CL System
- Error Prevention During Quality Control on the AQUIOS CL System
- Error Prevention Features of the AQUIOS CL Overview
- Error Prevention at Start Up / Cleaning / Worklist Generation on the AQUIOS CL System
-
CD4 Cell Counting Must Not be Sidelined if We are to Beat AIDS
- World Health Organization Guidelines Reinforce Role of CD4 Cell Counting in Immunocompromised Patients
- CD4 Cell Counting Must not be Sidelined if we are to Beat AIDS
- Funding drives Countries to Choose Between CD4 testing and Viral Load - Campaigners Need to Step Up and Shout About Why it’s so Significant to use Both
-
CD4 Testing in Remote Areas
- How Uganda is Leaving No-One Behind in Battle Against HIV
- Bringing High Quality Near-Patient Testing into Rural Communities
- CD4 Testing is an Efficient Way to Get Blood Samples
- Demonstrating how to Improve Operational Efficiency in Uganda’s Overall Laboratory Service - Part 1
- Demonstrating How to Improve Operational Efficiency in Uganda’s Overall Pathology Service - Part 2
- Demonstrating How to Improve Operational Efficiency in Uganda’s Overall Pathology Service - Part 3
- Demonstrating Operational Efficiency in Uganda Part 4
- Innovation In CD4 Testing
- The Impact of Laboratory Proficiency Testing And External Quality Assurance Schemes In Resource Limited Settings - From The Perspective Of Hazel Aggett, An Expert On Managing Africa’s Quality Control Schemes
- What is CD4 & Why is it Important?
- An Overview of the Current Status for the Global HIV/AIDS Pandemic
- UNAIDS 90-90-90
- Nanoparticle Research
-
Exosomes
- Interviews
- Simplifying Exosome Isolation
- Basic Exosome Research
- Cell-Based Assays
- Cell Signaling
- About Exosomes
- Applied Exosome Research
- Apoptosis Detection
- Exosomes Take Disease Modeling to the Next Level: From the Cage to the Plate
- Deciphering Disease using Exosome Biomarkers
- Targeting Efficient Drug Delivery With Exosome Nanoparticles
- Exosome Isolation
- Isolation and Characterization of Exosomes for Assays Approaches
- Exosomes: Moving Cancer Research Forward ~100 nm at a Time
- Instruments used in exosome research
-
Small Particle
- Verifying for Small Particle with Certified Beads
- Characterization of Extracellular Vesicles with Nanoscale Flow Cytometry
- Measuring Single EVs and their Cargo: Sensitive and Specific Vesicle Flow Cytometry (vFCTM)
- Things to Consider for Small Particle Research
- Western Blot and Other Methods vs. Nanoscale Flow Cytometry
- About Biological Nanoparticles and Microparticles
- Easy to Learn: A New User CytoFLEX Experience
- A Discovery in the Williams Lab
- Trends in Extracellular Vesicle Research
- Free Extracellular Vesicles Poster For Your Lab
- Nanoscale Frequently Asked Questions
- Small Talk
- Karan's Story
- Astrios and the Nanoscale
- Cell Sorting at the Nano Scale
- The Importance of Guidelines in Small Particle Research
- How the CytoFLEX Enabled The Williams' Lab Extracellular Vesicles Research
- Products
- Stem Cells
- Biologics
-
Immunotherapy